Search Within

Sloan Kettering Institute Postdocs

Formats
  1. Journal Article (8036)
  2. Meeting Abstract (3693)
  3. Review (630)
  4. Editorial (262)
  5. Book Section (195)
  6. Conference Paper (161)
  7. Research Letter (139)
  8. Correspondence (68)
  9. Miscellaneous (67)
  10. Guidelines (30)
  11. Book Whole (6)
Groups
  1. GSK Faculty (6363)
  2. Department of Medicine (4809)
  3. Sloan Kettering Institute Faculty (3570)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (3037)
  5. Surgery (2633)
  6. Solid Tumor Oncology Division (2604)

More Groups

People
  1. Britta Weigelt (376)
  2. Jorge Reis-Filho (328)
  3. Mithat Gonen (318)
  4. Marc Ladanyi (309)
  5. Michael Berger (288)
  6. Joseph Deasy (285)

More People

Years
  1. 2026 (1)
  2. 2025 (697)
  3. 2024 (1080)
  4. 2023 (1152)
  5. 2022 (1366)
  6. 2021 (1179)

More Years

Publications
  1. Blood (680)
  2. Cancer Research (543)
  3. Journal of Clinical Oncology (431)
  4. Journal of Nuclear Medicine (271)
  5. Annals of Surgical Oncology (264)
  6. Clinical Cancer Research (249)

More Publications

Publishers
  1. Nature Publishing Group (1349)
  2. Elsevier Inc. (1106)
  3. American Association for Cancer Research (1058)
  4. Springer (840)
  5. American Society of Hematology (740)
  6. Cell Press (740)

More Publishers

Results (13287)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tumour growth rate (TGR) when using lanreotide Autogel® (LAN) before, during and after peptide receptor radionuclide therapy (PRRT) in advanced neuroendocrine tumours (NETs)
    Meeting Abstract

    Prasad, V.; Srirajaskanthan, R.; Grana, C. M.; Baldari, S.; Shah, T.; Lamarca, A.; Courbon, F.; Scheidhauer, K.; Baudin, E.; Truong-Thanh, X. M.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • ABP-100: A tetravalent bispecific T-cell engaging antibody for HER2+ solid tumors
    Meeting Abstract

    Boudot, A.; Huang, X.; Murphy, S.; Appleman, V.; Xu, H.; Cheung, N. K.; Macbeath, G.
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Refusing to TAP out: 16 new human TEIPPs identified
    Journal Article

    Gigoux, M.; Wolchok, J.
    Journal of Experimental Medicine (2018)

    Fulltext@MSK | Save
  • Mucosal-associated invariant and γδ T cell subsets respond to initial Mycobacterium tuberculosis infection
    Journal Article

    Vorkas, C. K.; Wipperman, M. F.; Li, K.; Bean, J.; Bhattarai, S. K.; Adamow, M.; Wong, P.; Aubé, J.; Juste, M. A. J.; Bucci, V.; more...
    JCI Insight (2018)

    Fulltext@MSK | Save
  • Targeting the CALR interactome in myeloproliferative neoplasms
    Journal Article

    Pronier, E.; Cifani, P.; Merlinsky, T. R.; Berman, K. B.; Somasundara, A. V. H.; Rampal, R. K.; LaCava, J.; Wei, K. E.; Pastore, F.; Maag, J. L. V.; more...
    JCI Insight (2018)

    Fulltext@MSK | Save
  • Crowd counting with fully convolutional neural network
    Conference Paper

    Liu, M.; Jiang, J.; Guo, Z.; Wang, Z.; Liu, Y.
    IEEE (2018)

    Fulltext@MSK | Save
  • Commensal bacteria Bifidobacterium stimulates an anti-tumor response via cross-reactivity
    Meeting Abstract

    Bessell, C.; Bessell, C.; Isser, A.; Havel, J.; Lee, S.; Zhou, R.; Schneck, J.; Bell, D.
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • T cell immunotherapies trigger innate immunity and aseptic inflammation leading to potent anti-tumor and off-targets effects
    Meeting Abstract

    Hirschhorn-Cymerman, D.; Ricca, J.; Gasmi, B.; De Henau, O.; Mangarin, L.; Budhu, S.; Li, Y.; Cortez, C.; Liu, C.; Zappasodi, R.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • Targeting phosphatidylserine enhances the anti-tumor response to radiation therapy and immune checkpoint blockade in a preclinical melanoma model
    Meeting Abstract

    Budhu, S.; Giese, R.; Gupta, A.; Schad, S.; De Henau, O.; Zappasodi, R.; Campesato, L.; Barker, C.; Wolchok, J.; Merghoub, T.
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • Developing a cross-reactive heteroclitic peptide cancer vaccine targetting poorly immunogenic mutant calreticulin in myeloproliferative neoplasms
    Meeting Abstract

    Gigoux, M.; Elf, S.; Ciboddo, M.; Zappasodi, R.; Pourpe, S.; Abdelfattah, N.; Chan, T.; Abdel-Wahab, O.; Mullally, A.; Merghoub, T.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save